Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Kappa Free Light Chain (FLC)
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA | RD194088100R
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
What is KAPPA / LAMBDA LIGHT CHAINS FREE SERUM Test ?
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Living With - HealthTree for Myeloma
What are Free Kappa Light Chains, Serum? – HealthMatters.io – Lab results explained